Mentice AB
MN2
Company Profile
Business description
Mentice AB is engaged in the provision of software and hardware simulation solutions for endovascular therapies. Its solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. It operates through three segments: Mentice VIST, Physical Sim, and Ankyras. Geographically majority of the revenue is generated from the Americas, then followed by EMEA.
Contact
Odinsgatan 10
Gothenburg411 03
SWET: +46 313399400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
135
Stocks News & Analysis
stocks
Nvidia: Full steam ahead with an impressive array of announcements at CES 2026
Our view of Nvidia at the current share price.
stocks
Cheapest ASX member of our Best Idea’s list
This share is trading at the lowest price to fair value of the 14 companies on the list.
stocks
We remove our Moat Rating from ASX listed share
Despite a surging share price a weakening competitive position causes a reassessment of our view.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,996.90 | 78.80 | -0.87% |
| CAC 40 | 8,237.78 | 26.28 | 0.32% |
| DAX 40 | 24,934.63 | 65.94 | 0.27% |
| Dow JONES (US) | 49,139.55 | 162.37 | 0.33% |
| FTSE 100 | 10,122.71 | 118.14 | 1.18% |
| HKSE | 26,710.45 | 363.21 | 1.38% |
| NASDAQ | 23,501.04 | 105.22 | 0.45% |
| Nikkei 225 | 52,518.08 | 685.28 | 1.32% |
| NZX 50 Index | 13,663.58 | 76.35 | 0.56% |
| S&P 500 | 6,928.97 | 26.92 | 0.39% |
| S&P/ASX 200 | 8,682.80 | 88.50 | -1.01% |
| SSE Composite Index | 4,083.67 | 60.25 | 1.50% |